Publication date: 2026 Source: EJC Skin Cancer, Volume 4, Supplement 1 Author(s): K.-W. Noh, Y. Tolkach, D. Helbig, V.M. Barroso, Y. Foerster, M. Schlaak, T. Biedermann, R. Büttner, O.-D. Persa
A-211 - Toward Safe Discontinuation of Immunotherapy in Melanoma: A Multimodal Predictive Model for Relapse Risk. // EJC Skin Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S2772611826003290?dgcid=rss_sd_all
A-211 - Toward Safe Discontinuation of Immunotherapy in Melanoma: A Multimodal Predictive Model for Relapse Risk. EJC Skin Cancer. https://www.sciencedirect.com/science/article/pii/S2772611826003290?dgcid=rss_sd_all
“A-211 - Toward Safe Discontinuation of Immunotherapy in Melanoma: A Multimodal Predictive Model for Relapse Risk.” EJC Skin Cancer.
@article{article116682,
title = {A-211 - Toward Safe Discontinuation of Immunotherapy in Melanoma: A Multimodal Predictive Model for Relapse Risk},
journal = {EJC Skin Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S2772611826003290?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment